Drug Shortage Report for MISOPROSTOL
Report ID | 188329 |
Drug Identification Number | 02244022 |
Brand name | MISOPROSTOL |
Common or Proper name | Misoprostol |
Company Name | AA PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | MISOPROSTOL |
Strength(s) | 100MCG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100BTL |
ATC code | A02BB |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2023-03-30 |
Actual start date | |
Estimated end date | 2023-05-26 |
Actual end date | 2023-05-12 |
Shortage status | Resolved |
Updated date | 2023-05-13 |
Company comments | It is available only under allocation |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-03-30 | English | Compare |
v2 | 2023-03-30 | French | Compare |
v3 | 2023-03-31 | English | Compare |
v4 | 2023-04-04 | English | Compare |
v5 | 2023-04-04 | French | Compare |
v6 | 2023-04-25 | English | Compare |
v7 | 2023-04-25 | French | Compare |
v8 | 2023-05-12 | English | Compare |
v9 | 2023-05-12 | French | Compare |
v10 | 2023-05-13 | English | Compare |
Showing 1 to 10 of 10